BridgeBio Pharma (BBIO) Business News Oct. 28, 2025, 20:01 UTC BridgeBio to Report Phase 3 Results for Encaleret in ADH1 CALIBRATE Study on Wednesday, October 29th Full text
There are no comments here yet...